Global Anticancer Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.
The global Anticancer Drugs market size is projected to grow from US$ 201610 million in 2024 to US$ 391180 million in 2030; it is expected to grow at a CAGR of 11.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Anticancer Drugs Industry Forecast” looks at past sales and reviews total world Anticancer Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anticancer Drugs sales for 2023 through 2029. With Anticancer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticancer Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anticancer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anticancer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticancer Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticancer Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticancer Drugs.
Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.
The global Anticancer Drugs market size is projected to grow from US$ 201610 million in 2024 to US$ 391180 million in 2030; it is expected to grow at a CAGR of 11.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Anticancer Drugs Industry Forecast” looks at past sales and reviews total world Anticancer Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anticancer Drugs sales for 2023 through 2029. With Anticancer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticancer Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anticancer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anticancer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticancer Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticancer Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticancer Drugs.
Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cancer Immunotherapy
- Targeted Therapy
- Chemotherapy
- Other
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cancer Immunotherapy
- Targeted Therapy
- Chemotherapy
- Other
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- GSK
- Exelixis
- Regeneron
- Innovent
- Hengrui Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anticancer Drugs Market Size 2019-2030
2.1.2 Anticancer Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Anticancer Drugs by Country/Region, 2019, 2023 & 2030
2.2 Anticancer Drugs Segment by Type
2.2.1 Cancer Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Other
2.3 Anticancer Drugs Market Size by Type
2.3.1 Anticancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anticancer Drugs Market Size Market Share by Type (2019-2024)
2.4 Anticancer Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Prostate Cancer
2.4.4 Blood-related Cancer
2.4.5 Other
2.5 Anticancer Drugs Market Size by Application
2.5.1 Anticancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anticancer Drugs Market Size Market Share by Application (2019-2024)
3 ANTICANCER DRUGS MARKET SIZE BY PLAYER
3.1 Anticancer Drugs Market Size Market Share by Player
3.1.1 Global Anticancer Drugs Revenue by Player (2019-2024)
3.1.2 Global Anticancer Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Anticancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTICANCER DRUGS BY REGION
4.1 Anticancer Drugs Market Size by Region (2019-2024)
4.2 Global Anticancer Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anticancer Drugs Market Size Growth (2019-2024)
4.4 APAC Anticancer Drugs Market Size Growth (2019-2024)
4.5 Europe Anticancer Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Anticancer Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anticancer Drugs Market Size by Country (2019-2024)
5.2 Americas Anticancer Drugs Market Size by Type (2019-2024)
5.3 Americas Anticancer Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticancer Drugs Market Size by Region (2019-2024)
6.2 APAC Anticancer Drugs Market Size by Type (2019-2024)
6.3 APAC Anticancer Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anticancer Drugs Market Size by Country (2019-2024)
7.2 Europe Anticancer Drugs Market Size by Type (2019-2024)
7.3 Europe Anticancer Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anticancer Drugs by Region (2019-2024)
8.2 Middle East & Africa Anticancer Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Anticancer Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTICANCER DRUGS MARKET FORECAST
10.1 Global Anticancer Drugs Forecast by Region (2025-2030)
10.1.1 Global Anticancer Drugs Forecast by Region (2025-2030)
10.1.2 Americas Anticancer Drugs Forecast
10.1.3 APAC Anticancer Drugs Forecast
10.1.4 Europe Anticancer Drugs Forecast
10.1.5 Middle East & Africa Anticancer Drugs Forecast
10.2 Americas Anticancer Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Anticancer Drugs Forecast
10.2.2 Canada Market Anticancer Drugs Forecast
10.2.3 Mexico Market Anticancer Drugs Forecast
10.2.4 Brazil Market Anticancer Drugs Forecast
10.3 APAC Anticancer Drugs Forecast by Region (2025-2030)
10.3.1 China Anticancer Drugs Market Forecast
10.3.2 Japan Market Anticancer Drugs Forecast
10.3.3 Korea Market Anticancer Drugs Forecast
10.3.4 Southeast Asia Market Anticancer Drugs Forecast
10.3.5 India Market Anticancer Drugs Forecast
10.3.6 Australia Market Anticancer Drugs Forecast
10.4 Europe Anticancer Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Anticancer Drugs Forecast
10.4.2 France Market Anticancer Drugs Forecast
10.4.3 UK Market Anticancer Drugs Forecast
10.4.4 Italy Market Anticancer Drugs Forecast
10.4.5 Russia Market Anticancer Drugs Forecast
10.5 Middle East & Africa Anticancer Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Anticancer Drugs Forecast
10.5.2 South Africa Market Anticancer Drugs Forecast
10.5.3 Israel Market Anticancer Drugs Forecast
10.5.4 Turkey Market Anticancer Drugs Forecast
10.6 Global Anticancer Drugs Forecast by Type (2025-2030)
10.7 Global Anticancer Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Anticancer Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anticancer Drugs Product Offered
11.1.3 AbbVie Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Anticancer Drugs Product Offered
11.2.3 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Anticancer Drugs Product Offered
11.3.3 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Anticancer Drugs Product Offered
11.4.3 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Anticancer Drugs Product Offered
11.5.3 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Anticancer Drugs Product Offered
11.6.3 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Anticancer Drugs Product Offered
11.7.3 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Anticancer Drugs Product Offered
11.8.3 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Anticancer Drugs Product Offered
11.9.3 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Anticancer Drugs Product Offered
11.10.3 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Anticancer Drugs Product Offered
11.11.3 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Anticancer Drugs Product Offered
11.12.3 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Anticancer Drugs Product Offered
11.13.3 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Anticancer Drugs Product Offered
11.14.3 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Anticancer Drugs Product Offered
11.15.3 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Anticancer Drugs Product Offered
11.16.3 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
11.17 Exelixis
11.17.1 Exelixis Company Information
11.17.2 Exelixis Anticancer Drugs Product Offered
11.17.3 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Exelixis Main Business Overview
11.17.5 Exelixis Latest Developments
11.18 Regeneron
11.18.1 Regeneron Company Information
11.18.2 Regeneron Anticancer Drugs Product Offered
11.18.3 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Regeneron Main Business Overview
11.18.5 Regeneron Latest Developments
11.19 Innovent
11.19.1 Innovent Company Information
11.19.2 Innovent Anticancer Drugs Product Offered
11.19.3 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Innovent Main Business Overview
11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Anticancer Drugs Product Offered
11.20.3 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anticancer Drugs Market Size 2019-2030
2.1.2 Anticancer Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Anticancer Drugs by Country/Region, 2019, 2023 & 2030
2.2 Anticancer Drugs Segment by Type
2.2.1 Cancer Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Chemotherapy
2.2.4 Other
2.3 Anticancer Drugs Market Size by Type
2.3.1 Anticancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anticancer Drugs Market Size Market Share by Type (2019-2024)
2.4 Anticancer Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Prostate Cancer
2.4.4 Blood-related Cancer
2.4.5 Other
2.5 Anticancer Drugs Market Size by Application
2.5.1 Anticancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anticancer Drugs Market Size Market Share by Application (2019-2024)
3 ANTICANCER DRUGS MARKET SIZE BY PLAYER
3.1 Anticancer Drugs Market Size Market Share by Player
3.1.1 Global Anticancer Drugs Revenue by Player (2019-2024)
3.1.2 Global Anticancer Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Anticancer Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTICANCER DRUGS BY REGION
4.1 Anticancer Drugs Market Size by Region (2019-2024)
4.2 Global Anticancer Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anticancer Drugs Market Size Growth (2019-2024)
4.4 APAC Anticancer Drugs Market Size Growth (2019-2024)
4.5 Europe Anticancer Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Anticancer Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Anticancer Drugs Market Size by Country (2019-2024)
5.2 Americas Anticancer Drugs Market Size by Type (2019-2024)
5.3 Americas Anticancer Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticancer Drugs Market Size by Region (2019-2024)
6.2 APAC Anticancer Drugs Market Size by Type (2019-2024)
6.3 APAC Anticancer Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Anticancer Drugs Market Size by Country (2019-2024)
7.2 Europe Anticancer Drugs Market Size by Type (2019-2024)
7.3 Europe Anticancer Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anticancer Drugs by Region (2019-2024)
8.2 Middle East & Africa Anticancer Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Anticancer Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTICANCER DRUGS MARKET FORECAST
10.1 Global Anticancer Drugs Forecast by Region (2025-2030)
10.1.1 Global Anticancer Drugs Forecast by Region (2025-2030)
10.1.2 Americas Anticancer Drugs Forecast
10.1.3 APAC Anticancer Drugs Forecast
10.1.4 Europe Anticancer Drugs Forecast
10.1.5 Middle East & Africa Anticancer Drugs Forecast
10.2 Americas Anticancer Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Anticancer Drugs Forecast
10.2.2 Canada Market Anticancer Drugs Forecast
10.2.3 Mexico Market Anticancer Drugs Forecast
10.2.4 Brazil Market Anticancer Drugs Forecast
10.3 APAC Anticancer Drugs Forecast by Region (2025-2030)
10.3.1 China Anticancer Drugs Market Forecast
10.3.2 Japan Market Anticancer Drugs Forecast
10.3.3 Korea Market Anticancer Drugs Forecast
10.3.4 Southeast Asia Market Anticancer Drugs Forecast
10.3.5 India Market Anticancer Drugs Forecast
10.3.6 Australia Market Anticancer Drugs Forecast
10.4 Europe Anticancer Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Anticancer Drugs Forecast
10.4.2 France Market Anticancer Drugs Forecast
10.4.3 UK Market Anticancer Drugs Forecast
10.4.4 Italy Market Anticancer Drugs Forecast
10.4.5 Russia Market Anticancer Drugs Forecast
10.5 Middle East & Africa Anticancer Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Anticancer Drugs Forecast
10.5.2 South Africa Market Anticancer Drugs Forecast
10.5.3 Israel Market Anticancer Drugs Forecast
10.5.4 Turkey Market Anticancer Drugs Forecast
10.6 Global Anticancer Drugs Forecast by Type (2025-2030)
10.7 Global Anticancer Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Anticancer Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anticancer Drugs Product Offered
11.1.3 AbbVie Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Anticancer Drugs Product Offered
11.2.3 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Anticancer Drugs Product Offered
11.3.3 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Anticancer Drugs Product Offered
11.4.3 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Anticancer Drugs Product Offered
11.5.3 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Anticancer Drugs Product Offered
11.6.3 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Anticancer Drugs Product Offered
11.7.3 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Anticancer Drugs Product Offered
11.8.3 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Anticancer Drugs Product Offered
11.9.3 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Anticancer Drugs Product Offered
11.10.3 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Anticancer Drugs Product Offered
11.11.3 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Anticancer Drugs Product Offered
11.12.3 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Anticancer Drugs Product Offered
11.13.3 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Anticancer Drugs Product Offered
11.14.3 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Anticancer Drugs Product Offered
11.15.3 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Anticancer Drugs Product Offered
11.16.3 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
11.17 Exelixis
11.17.1 Exelixis Company Information
11.17.2 Exelixis Anticancer Drugs Product Offered
11.17.3 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Exelixis Main Business Overview
11.17.5 Exelixis Latest Developments
11.18 Regeneron
11.18.1 Regeneron Company Information
11.18.2 Regeneron Anticancer Drugs Product Offered
11.18.3 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Regeneron Main Business Overview
11.18.5 Regeneron Latest Developments
11.19 Innovent
11.19.1 Innovent Company Information
11.19.2 Innovent Anticancer Drugs Product Offered
11.19.3 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Innovent Main Business Overview
11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Anticancer Drugs Product Offered
11.20.3 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anticancer Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Anticancer Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cancer Immunotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Other
Table 7. Anticancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Anticancer Drugs Market Size Market Share by Type (2019-2024)
Table 10. Anticancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Anticancer Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Anticancer Drugs Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Anticancer Drugs Revenue Market Share by Player (2019-2024)
Table 15. Anticancer Drugs Key Players Head office and Products Offered
Table 16. Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Anticancer Drugs Market Size Market Share by Region (2019-2024)
Table 21. Global Anticancer Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Anticancer Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Anticancer Drugs Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Anticancer Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Anticancer Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Anticancer Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Anticancer Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Anticancer Drugs Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Anticancer Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Anticancer Drugs
Table 41. Key Market Challenges & Risks of Anticancer Drugs
Table 42. Key Industry Trends of Anticancer Drugs
Table 43. Global Anticancer Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Anticancer Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Anticancer Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Anticancer Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. AbbVie Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 48. AbbVie Anticancer Drugs Product Offered
Table 49. AbbVie Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. AbbVie Main Business
Table 51. AbbVie Latest Developments
Table 52. Johnson & Johnson Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 53. Johnson & Johnson Anticancer Drugs Product Offered
Table 54. Johnson & Johnson Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Novartis Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 58. Novartis Anticancer Drugs Product Offered
Table 59. Novartis Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Gilead Sciences Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 63. Gilead Sciences Anticancer Drugs Product Offered
Table 64. Gilead Sciences Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Sciences Main Business
Table 66. Gilead Sciences Latest Developments
Table 67. Roche Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 68. Roche Anticancer Drugs Product Offered
Table 69. Roche Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Anticancer Drugs Product Offered
Table 74. Bristol-Myers Squibb Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bristol-Myers Squibb Main Business
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Amgen Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 78. Amgen Anticancer Drugs Product Offered
Table 79. Amgen Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. AstraZeneca Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 83. AstraZeneca Anticancer Drugs Product Offered
Table 84. AstraZeneca Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Merck & Co Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 88. Merck & Co Anticancer Drugs Product Offered
Table 89. Merck & Co Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Merck & Co Main Business
Table 91. Merck & Co Latest Developments
Table 92. Takeda Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 93. Takeda Anticancer Drugs Product Offered
Table 94. Takeda Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Merck KGaA Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 98. Merck KGaA Anticancer Drugs Product Offered
Table 99. Merck KGaA Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Merck KGaA Main Business
Table 101. Merck KGaA Latest Developments
Table 102. Seagen Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 103. Seagen Anticancer Drugs Product Offered
Table 104. Seagen Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Seagen Main Business
Table 106. Seagen Latest Developments
Table 107. Eli Lilly Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 108. Eli Lilly Anticancer Drugs Product Offered
Table 109. Eli Lilly Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Latest Developments
Table 112. Ono Pharmaceutical Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 113. Ono Pharmaceutical Anticancer Drugs Product Offered
Table 114. Ono Pharmaceutical Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Ono Pharmaceutical Main Business
Table 116. Ono Pharmaceutical Latest Developments
Table 117. Pfizer Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 118. Pfizer Anticancer Drugs Product Offered
Table 119. Pfizer Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. GSK Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 123. GSK Anticancer Drugs Product Offered
Table 124. GSK Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. GSK Main Business
Table 126. GSK Latest Developments
Table 127. Exelixis Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 128. Exelixis Anticancer Drugs Product Offered
Table 129. Exelixis Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Exelixis Main Business
Table 131. Exelixis Latest Developments
Table 132. Regeneron Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 133. Regeneron Anticancer Drugs Product Offered
Table 134. Regeneron Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. Regeneron Main Business
Table 136. Regeneron Latest Developments
Table 137. Innovent Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 138. Innovent Anticancer Drugs Product Offered
Table 139. Innovent Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Innovent Main Business
Table 141. Innovent Latest Developments
Table 142. Hengrui Medicine Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 143. Hengrui Medicine Anticancer Drugs Product Offered
Table 144. Hengrui Medicine Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 145. Hengrui Medicine Main Business
Table 146. Hengrui Medicine Latest Developments
Table 1. Anticancer Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Anticancer Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Cancer Immunotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Other
Table 7. Anticancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 8. Global Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 9. Global Anticancer Drugs Market Size Market Share by Type (2019-2024)
Table 10. Anticancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 12. Global Anticancer Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Anticancer Drugs Revenue by Player (2019-2024) & ($ millions)
Table 14. Global Anticancer Drugs Revenue Market Share by Player (2019-2024)
Table 15. Anticancer Drugs Key Players Head office and Products Offered
Table 16. Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 20. Global Anticancer Drugs Market Size Market Share by Region (2019-2024)
Table 21. Global Anticancer Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Anticancer Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Anticancer Drugs Market Size by Country (2019-2024) & ($ millions)
Table 24. Americas Anticancer Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 26. Americas Anticancer Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 28. Americas Anticancer Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 30. APAC Anticancer Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 32. APAC Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 33. Europe Anticancer Drugs Market Size by Country (2019-2024) & ($ millions)
Table 34. Europe Anticancer Drugs Market Size Market Share by Country (2019-2024)
Table 35. Europe Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. Europe Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Middle East & Africa Anticancer Drugs Market Size by Region (2019-2024) & ($ millions)
Table 38. Middle East & Africa Anticancer Drugs Market Size by Type (2019-2024) & ($ millions)
Table 39. Middle East & Africa Anticancer Drugs Market Size by Application (2019-2024) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Anticancer Drugs
Table 41. Key Market Challenges & Risks of Anticancer Drugs
Table 42. Key Industry Trends of Anticancer Drugs
Table 43. Global Anticancer Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 44. Global Anticancer Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 45. Global Anticancer Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 46. Global Anticancer Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 47. AbbVie Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 48. AbbVie Anticancer Drugs Product Offered
Table 49. AbbVie Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 50. AbbVie Main Business
Table 51. AbbVie Latest Developments
Table 52. Johnson & Johnson Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 53. Johnson & Johnson Anticancer Drugs Product Offered
Table 54. Johnson & Johnson Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Johnson & Johnson Main Business
Table 56. Johnson & Johnson Latest Developments
Table 57. Novartis Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 58. Novartis Anticancer Drugs Product Offered
Table 59. Novartis Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Gilead Sciences Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 63. Gilead Sciences Anticancer Drugs Product Offered
Table 64. Gilead Sciences Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Sciences Main Business
Table 66. Gilead Sciences Latest Developments
Table 67. Roche Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 68. Roche Anticancer Drugs Product Offered
Table 69. Roche Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Bristol-Myers Squibb Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 73. Bristol-Myers Squibb Anticancer Drugs Product Offered
Table 74. Bristol-Myers Squibb Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bristol-Myers Squibb Main Business
Table 76. Bristol-Myers Squibb Latest Developments
Table 77. Amgen Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 78. Amgen Anticancer Drugs Product Offered
Table 79. Amgen Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Amgen Main Business
Table 81. Amgen Latest Developments
Table 82. AstraZeneca Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 83. AstraZeneca Anticancer Drugs Product Offered
Table 84. AstraZeneca Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Merck & Co Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 88. Merck & Co Anticancer Drugs Product Offered
Table 89. Merck & Co Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Merck & Co Main Business
Table 91. Merck & Co Latest Developments
Table 92. Takeda Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 93. Takeda Anticancer Drugs Product Offered
Table 94. Takeda Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Merck KGaA Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 98. Merck KGaA Anticancer Drugs Product Offered
Table 99. Merck KGaA Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Merck KGaA Main Business
Table 101. Merck KGaA Latest Developments
Table 102. Seagen Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 103. Seagen Anticancer Drugs Product Offered
Table 104. Seagen Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Seagen Main Business
Table 106. Seagen Latest Developments
Table 107. Eli Lilly Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 108. Eli Lilly Anticancer Drugs Product Offered
Table 109. Eli Lilly Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Eli Lilly Main Business
Table 111. Eli Lilly Latest Developments
Table 112. Ono Pharmaceutical Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 113. Ono Pharmaceutical Anticancer Drugs Product Offered
Table 114. Ono Pharmaceutical Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Ono Pharmaceutical Main Business
Table 116. Ono Pharmaceutical Latest Developments
Table 117. Pfizer Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 118. Pfizer Anticancer Drugs Product Offered
Table 119. Pfizer Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Pfizer Main Business
Table 121. Pfizer Latest Developments
Table 122. GSK Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 123. GSK Anticancer Drugs Product Offered
Table 124. GSK Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. GSK Main Business
Table 126. GSK Latest Developments
Table 127. Exelixis Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 128. Exelixis Anticancer Drugs Product Offered
Table 129. Exelixis Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 130. Exelixis Main Business
Table 131. Exelixis Latest Developments
Table 132. Regeneron Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 133. Regeneron Anticancer Drugs Product Offered
Table 134. Regeneron Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 135. Regeneron Main Business
Table 136. Regeneron Latest Developments
Table 137. Innovent Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 138. Innovent Anticancer Drugs Product Offered
Table 139. Innovent Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 140. Innovent Main Business
Table 141. Innovent Latest Developments
Table 142. Hengrui Medicine Details, Company Type, Anticancer Drugs Area Served and Its Competitors
Table 143. Hengrui Medicine Anticancer Drugs Product Offered
Table 144. Hengrui Medicine Anticancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 145. Hengrui Medicine Main Business
Table 146. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Anticancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticancer Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Anticancer Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anticancer Drugs Sales Market Share by Country/Region (2023)
Figure 8. Anticancer Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anticancer Drugs Market Size Market Share by Type in 2023
Figure 10. Anticancer Drugs in Lung Cancer
Figure 11. Global Anticancer Drugs Market: Lung Cancer (2019-2024) & ($ millions)
Figure 12. Anticancer Drugs in Breast Cancer
Figure 13. Global Anticancer Drugs Market: Breast Cancer (2019-2024) & ($ millions)
Figure 14. Anticancer Drugs in Prostate Cancer
Figure 15. Global Anticancer Drugs Market: Prostate Cancer (2019-2024) & ($ millions)
Figure 16. Anticancer Drugs in Blood-related Cancer
Figure 17. Global Anticancer Drugs Market: Blood-related Cancer (2019-2024) & ($ millions)
Figure 18. Anticancer Drugs in Other
Figure 19. Global Anticancer Drugs Market: Other (2019-2024) & ($ millions)
Figure 20. Global Anticancer Drugs Market Size Market Share by Application in 2023
Figure 21. Global Anticancer Drugs Revenue Market Share by Player in 2023
Figure 22. Global Anticancer Drugs Market Size Market Share by Region (2019-2024)
Figure 23. Americas Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 24. APAC Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 25. Europe Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 27. Americas Anticancer Drugs Value Market Share by Country in 2023
Figure 28. United States Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Anticancer Drugs Market Size Market Share by Region in 2023
Figure 33. APAC Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 34. APAC Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 35. China Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. India Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Anticancer Drugs Market Size Market Share by Country in 2023
Figure 42. Europe Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 43. Europe Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 44. Germany Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. France Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Anticancer Drugs Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 58. APAC Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 59. Europe Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 61. United States Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 62. Canada Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 63. Mexico Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 64. Brazil Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 65. China Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 66. Japan Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 67. Korea Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 69. India Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 70. Australia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 71. Germany Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 72. France Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 73. UK Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 74. Italy Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 75. Russia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 76. Egypt Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 77. South Africa Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 78. Israel Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 79. Turkey Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 81. Global Anticancer Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Anticancer Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Anticancer Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticancer Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Anticancer Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Anticancer Drugs Sales Market Share by Country/Region (2023)
Figure 8. Anticancer Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Anticancer Drugs Market Size Market Share by Type in 2023
Figure 10. Anticancer Drugs in Lung Cancer
Figure 11. Global Anticancer Drugs Market: Lung Cancer (2019-2024) & ($ millions)
Figure 12. Anticancer Drugs in Breast Cancer
Figure 13. Global Anticancer Drugs Market: Breast Cancer (2019-2024) & ($ millions)
Figure 14. Anticancer Drugs in Prostate Cancer
Figure 15. Global Anticancer Drugs Market: Prostate Cancer (2019-2024) & ($ millions)
Figure 16. Anticancer Drugs in Blood-related Cancer
Figure 17. Global Anticancer Drugs Market: Blood-related Cancer (2019-2024) & ($ millions)
Figure 18. Anticancer Drugs in Other
Figure 19. Global Anticancer Drugs Market: Other (2019-2024) & ($ millions)
Figure 20. Global Anticancer Drugs Market Size Market Share by Application in 2023
Figure 21. Global Anticancer Drugs Revenue Market Share by Player in 2023
Figure 22. Global Anticancer Drugs Market Size Market Share by Region (2019-2024)
Figure 23. Americas Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 24. APAC Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 25. Europe Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Anticancer Drugs Market Size 2019-2024 ($ millions)
Figure 27. Americas Anticancer Drugs Value Market Share by Country in 2023
Figure 28. United States Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Anticancer Drugs Market Size Market Share by Region in 2023
Figure 33. APAC Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 34. APAC Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 35. China Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. India Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Anticancer Drugs Market Size Market Share by Country in 2023
Figure 42. Europe Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 43. Europe Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 44. Germany Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 45. France Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Anticancer Drugs Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Anticancer Drugs Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Anticancer Drugs Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Anticancer Drugs Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 58. APAC Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 59. Europe Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 61. United States Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 62. Canada Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 63. Mexico Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 64. Brazil Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 65. China Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 66. Japan Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 67. Korea Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 69. India Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 70. Australia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 71. Germany Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 72. France Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 73. UK Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 74. Italy Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 75. Russia Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 76. Egypt Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 77. South Africa Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 78. Israel Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 79. Turkey Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Anticancer Drugs Market Size 2025-2030 ($ millions)
Figure 81. Global Anticancer Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Anticancer Drugs Market Size Market Share Forecast by Application (2025-2030)
